13G Filing: Birchview Capital and Soleno Therapeutics Inc (SLNO)

Item 3.

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

(a)
¨ Broker or dealer
registered under section 15 of the Act (15 U.S.C. 78o);

(b)
¨ Bank as defined
in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)
¨ Insurance company
as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)
¨ Investment company
registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

(e) x
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)
¨ An employee benefit
plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)
¨ A parent holding
company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)
¨ A savings associations
as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)
¨ A church plan
that is excluded from the definition of an investment company under section 3(c)(14) of the

Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)
¨ Group, in accordance
with §240.13d-1(b)(1)(ii)(J).

Item 4.

Ownership:

Item 4(a).

Amount Beneficially Owned:

As of the date hereof, the Reporting Person may be deemed to
be the beneficial owner of 678,426 Shares and 502,037 Warrants.

Item 4(b).

Percent of Class:

As of the date hereof, the Reporting Person
may be deemed to be the beneficial owner of 6.166% of the total number of Shares outstanding.

Item 4(c).	Number of shares as to which such person has:

	Birchview Capital, LP

	(i)	Sole power to vote or direct the vote	1,180,463
	(ii)	Shared power to vote or to direct the vote	0
	(iii)	Sole power to dispose or to direct the disposition of	1,180,463
	(iv)	Shared power to dispose or to direct the disposition of	0

Page 3 of 4 – SEC Filing